Delcath Systems Files Q3 2024 10-Q
Ticker: DCTH · Form: 10-Q · Filed: Nov 8, 2024 · CIK: 872912
Sentiment: neutral
Topics: 10-Q, financials, healthcare
TL;DR
Delcath Systems filed its Q3 10-Q. Check financials for latest performance.
AI Summary
Delcath Systems, Inc. filed its 10-Q for the period ending September 30, 2024. The company reported its financial results and provided updates on its business operations. Specific financial figures and operational details are available within the full filing.
Why It Matters
This filing provides investors with the latest financial performance and operational status of Delcath Systems, Inc., crucial for understanding the company's trajectory.
Risk Assessment
Risk Level: medium — 10-Q filings are standard disclosures, but the specific financial health and operational details within this report will determine the actual risk.
Key Numbers
- 2024-09-30 — Period End Date (Financial reporting period)
- 2023-12-31 — Prior Year End Date (Comparison point for financial data)
Key Players & Entities
- DELCATH SYSTEMS, INC. (company) — Filer
- 20240930 (date) — Period of Report
- 20241108 (date) — Filing Date
FAQ
What were Delcath Systems' total assets as of September 30, 2024?
The filing does not explicitly state the total assets figure in the provided snippet, but it indicates the reporting period ends on 2024-09-30.
What is Delcath Systems' primary industry classification?
Delcath Systems, Inc. is classified under 'SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]'.
When was the company incorporated?
The company is incorporated in Delaware (DE).
What is the fiscal year end for Delcath Systems?
The fiscal year end for Delcath Systems is December 31 (1231).
What is the SEC file number for Delcath Systems?
The SEC file number for Delcath Systems is 001-16133.
Filing Stats: 4,818 words · 19 min read · ~16 pages · Grade level 18.9 · Accepted 2024-11-08 09:46:22
Key Financial Figures
- $0.01 — ange on which registered Common stock, $0.01 par value per share DCTH The Nasdaq Cap
Filing Documents
- dcth-20240930.htm (10-Q) — 1170KB
- dcth-20240930xexx311.htm (EX-31.1) — 10KB
- dcth-20240930xexx312.htm (EX-31.2) — 10KB
- dcth-20240930xexx321.htm (EX-32.1) — 5KB
- dcth-20240930xexx322.htm (EX-32.2) — 5KB
- 0001628280-24-046537.txt ( ) — 7834KB
- dcth-20240930.xsd (EX-101.SCH) — 69KB
- dcth-20240930_cal.xml (EX-101.CAL) — 72KB
- dcth-20240930_def.xml (EX-101.DEF) — 286KB
- dcth-20240930_lab.xml (EX-101.LAB) — 766KB
- dcth-20240930_pre.xml (EX-101.PRE) — 535KB
- dcth-20240930_htm.xml (XML) — 1082KB
—FINANCIAL INFORMATION
PART I—FINANCIAL INFORMATION Item 1.
Financial Statements
Financial Statements Unaudited Condensed Consolidated Balance Sheets as of September 30, 2024 and December 31, 2023 3 Unaudited Condensed Consolidated Statements of Operations and Comprehensive I ncome and Loss for the three and nine months ended September 30, 2024 and 2023 4 Unaudited Condensed Consolidated Statements of Stockholders' Equity for the three and nine months ended September 30, 2024 and 2023 5 Unaudited Condensed Consolidated Statements of Cash Flows for the nine months ended September 30, 2024 and 2023 7 Notes to the Unaudited Condensed Consolidated Financial Statements 9 Item 2.
Management's Discussion and Analysis of Financial Condition and Results of Operations
Management's Discussion and Analysis of Financial Condition and Results of Operations 25 Item 3.
Quantitative and Qualitative Disclosures About Market Risk
Quantitative and Qualitative Disclosures About Market Risk 30 Item 4.
Controls and Procedures
Controls and Procedures 30
—OTHER INFORMATION
PART II—OTHER INFORMATION 32 Item 1 .
Legal Proceedings
Legal Proceedings 32 Item 1A.
Unregistered Sales of Equity Securities and Use of Proceeds
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 32
Defaults Upon Senior Securities
Item 3. Defaults Upon Senior Securities 32
Mine Safety Disclosure
Item 4. Mine Safety Disclosure 32
Other Information
Item 5. Other Information 32 Item 6. Exhibits 33
SIGNATURES
SIGNATURES 36 2 Table of Contents DELCATH SYSTEMS, INC. Condensed Consolidated Balance Sheets (Unaudited) (in thousands, except share and per share data) September 30, 2024 December 31, 2023 Assets Current assets Cash and cash equivalents $ 8,315 $ 12,646 Restricted cash — 50 Short-term investments 5,677 19,808 Accounts receivable, net 6,936 241 Inventory 6,642 3,322 Prepaid expenses and other current assets 1,312 1,091 Total current assets 28,882 37,158 Property, plant and equipment, net 1,729 1,352 Right-of-use assets 1,070 103 Total assets $ 31,681 $ 38,613 Liabilities and Stockholders' Equity Current liabilities Accounts payable $ 937 $ 1,012 Accrued expenses 5,706 5,249 Lease liabilities, current 107 37 Loan payable — 5,239 Convertible notes payable 2,000 4,911 Warrant liability - current 12,834 — Total current liabilities 21,584 16,448 Warrant liability, non-current — 5,548 Lease Liabilities, non-current 963 — Other liabilities, non-current 563 840 Total liabilities $ 23,110 $ 22,836 Commitments and contingencies (see Note 14) Stockholders' equity Preferred stock, $ 0.01 par value; 10,000,000 shares authorized; 12,342 and 24,819 shares issued and outstanding at September 30, 2024 and December 31, 2023, respectively — — Common stock, $ 0.01 par value; 80,000,000 shares authorized; 28,019,599 shares and 22,761,554 shares issued and outstanding at September 30, 2024 and December 31, 2023, respectively 280 228 Additional paid-in capital 536,430 520,576 Accumulated deficit ( 528,150 ) ( 505,162 ) Accumulated other comprehensive income 11 135 Total stockholders' equity 8,571 15,777 Total liabilities and stockholders' equity $ 31,681 $ 38,613 See accompanying Notes to Unaudited Condensed Consolidated Financial Statements. 3 Table of Contents DELCATH SYSTEMS, INC. Condensed Consolidated Statements of Operations and Comprehensive Income and Loss (Unaudited) (in thousands, except share and per share data) Three